Abstract：Objective To study the influence of external adjuvant application of Fructus Evodiae plus Natrii Sulfas on the degree of systemic inflammatory response and target organ damage in patients with severe acute pancreatitis. Methods Eighty cases of patients with severe acute pancreatitis admitted to Guangdong Hospital of Traditional Chinese Medicine from February 2013 to January 2017 were collected, and the enrolled patients were divided into two groups by single blind randomized controlled method, with 40 cases in each group. The control group received conventional therapy, on basis of which, the observation group was added with external adjuvant application of Fructus Evodiae plus Natrii Sulfas. At admission, one week after treatment, the contents of serum inflammatory indexes were measured by enzyme linked immunosorbent assay (ELISA), the contents of serum liver function indexes were detected by semi automatic biochemical analyzer, the contents of intestinal mucosal barrier indexes were measured by spectrophotometer method. Results At admission, there were no significant differences in the degree of systemic inflammatory response, liver function and intestinal mucosal barrier function between the two groups (P ＞ 0.05). One week after treatment, the contents of serum interleukin-6 (IL-6), interleukin-8 (IL-6), monocyte chemoattractant protein-1 (MCP-1), alanine aminotransferase (ALT), total bilirubin (TBiL), alkaline phosphatase (AKP), lactic acid, D-amine oxidase (DAO), endotoxin of the two groups were significantly lower than those at admission, and the contents of serum IL-6, IL-8, MCP-1, ALT, TBiL, AKP, D-lactic acid, DAO, endotox of observation group were significantly lower than those of control group (P ＜ 0.05). Conclusion External adjuvant application of Fructus Evodiae plus Natrii Sulfas can alleviate the degree of systemic inflammatory response in patients with severe acute pancreatitis, and protect target organ function.
林丽君 周春姣 何军明 刘明 蔡炳勤. 吴茱萸+芒硝外用辅助干预用于重症胰腺炎的疗效研究[J]. 中国医药导报, 2017, 14(33): 147-150.
LIN Lijun ZHOU Chunjiao HE Junming LIU Ming CAI Bingqin. Study on the efficacy of external adjuvant application of Fructus Evodiae plus Natrii Sulfas on severe acute pancreatitis. 中国医药导报, 2017, 14(33): 147-150.
[1] 杨科，杨启，秦长岭.急性重症胰腺炎患者腹腔感染的临床诊断及治疗[J].中华医院感染学杂志，2015，25（5）：1122-1125.
[2] Hua Z，Su Y，Huang X，et al. Analysis of risk factors related to gastrointestinal fistula in patients with severe acute pancreatitis：a retrospective study of 344 cases in a single Chinese center [J]. BMC Gastroenterol，2017，17（1）：29.
[3] 谷欢，彭杰，莫吉祥.吴茱萸次碱治疗重症急性胰腺炎的实验研究[J].中国普通外科杂志，2014，23（3）：314-318.
[4] 朱妍，王志勤，林兆奋.谷氨酰胺联合早期肠内营养对急性重症胰腺炎患者氨基酸代谢细菌移位以及炎性反应的影响[J].海南医学院学报，2015，21（3）：347-350.
[5] Lin J，Li Z，Zheng Y，et al. Elevated Presepsin Levels are Associated with Severity and Prognosis of Severe Acute Pancreatitis [J]. Clin Lab，2016，62（9）：1699-1708.
[6] 莫吉祥，彭杰，彭燕，等.吴茱萸次碱联合乌司他丁治疗重症急性胰腺炎的实验研究[J].中国现代医学杂志，2012， 22（19）：32-35.
[7] 王伟，龚仁华，魏超，等.硫酸镁联合芒硝外敷早期干预急性重症胰腺炎的疗效观察[J].中医临床研究，2015，7（32）：45-48.
[8] 林启新，林海，钱剑.乌司他丁静脉滴注联合生大黄煎液灌肠对重症胰腺炎患者的疗效及炎症因子水平的改善效果分析[J].中华中医药学刊，2016，34（7）：1784-1787.
[9] Xiong J，Wang K，Yuan C，et al. Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects [J]. Int J Mol Med，2017，39（1）：113-125.
[10] 熊睿.生态免疫肠内营养干预重症胰腺炎大鼠模型肠道屏障功能、全身炎性反应的影响[J].海南医学院学报，2016，22（3）：212-215.
[11] Aleksandrova ED，Sadchikov DV，Kuligin AV. Optimization of antisecretory component of severe acute pancreatitis intensive management [J]. Khirurgiia（Mosk），2016（6）：83-85.
[12] Hong YP，Chen C，Guo WY，et al. Effects of Castanospermine on Inflammatory Response in a Rat Model of Experimental Severe Acute Pancreatitis [J]. Arch Med Res，2016，47（6）：436-445.
[13] 金琦，何其勇，董航，等.黄芩苷对急性重症胰腺炎大鼠受损肝组织保护作用的研究[J].中国现代医学杂志，2014， 24（8）：26-30.
[14] Chen Y，Ma L，Song X，et al. Beneficial effects of fluid resuscitation via the rectum on hemodynamic disorders and multiple organ injuries in an experimental severe acute pancreatitis model [J]. Pancreatology，2015，15（6）：626-634.
[15] Mok SR，Mohan S，Elfant AB，et al. The Acute Physiology and Chronic Health Evaluation Ⅳ，a New Scoring System for Predicting Mortality and Complications of Severe Acute Pancreatitis [J]. Pancreas，2015，44（8）：1314-1319.
[16] 张晓.胰瘅方内服和灌肠对重症胰腺炎肠黏膜屏障功能的影响[J].中国实验方剂学杂志，2014，20（16）：187-190.
[17] Schietroma M，Pessia B，Carlei F，et al. Intestinal permeability and systemic endotoxemia in patients with acute pancreatitis [J]. Ann Ital Chir，2016，87：138-144.
[18] Deng W，Abliz A，Xu S，et al. Severity of pancreatitis?associated intestinal mucosal barrier injury is reduced following treatment with the NADPH oxidase inhibitor apocynin [J]. Mol Med Rep，2016，14（4）：3525-3534.
[19] Ouyang J，Zhang ZH，Zhou YX，et al. Up-regulation of Tight-Junction Proteins by p38 Mitogen-Activated Protein Kinase/p53 Inhibition Leads to a Reduction of Injury to the Intestinal Mucosal Barrier in Severe Acute Pancreatitis [J]. Pancreas，2016，45（8）：1136-1144.
[20] 陈健，王磊，李炳庆，等.肠内营养支持治疗对急性重症胰腺炎肠黏膜屏障功能及细菌移位的影响[J].中国老年学杂志，2014，34（12）：3325-3328.
2017, Vol. 14 
京公网安备 11010502046598号